Assessment of Depression and Anxiety in Breast Cancer Patients Undergoing Radiotherapy in Palestine

ALMasri, Hussein; Rimawi, Omar

doi:10.1007/s42399-020-00635-z

Cited by 4 publications

(7 citation statements)

References 16 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Additionally, to more robustly assess if other treatments may affect the finding herein, we reanalyzed the relationships between CHM use and subsequent risk of depression by adjusting for the utilization numbers of radiotherapy after breast cancer onset. The rational underlying this procedure was based on the assumption that radiotherapy for breast cancer patients is an obligatory component of a breast-conserving treatment modality and could cause deleterious psychological symptoms in such a group of patients ( Almasri and Rimawi, 2020 ; Piroth et al, 2022 ). The re-analysis indicated that, as compared to breast cancer patients who did not receive CHM, the selected breast cancer patients who received CHM still had a significantly lower risk for depression (adjusted HR: 0.75; 95% CI = 0.59–0.89).…”

Section: Discussionmentioning

confidence: 99%

Association of Chinese herbal medicine use with the depression risk among the long-term breast cancer survivors: A longitudinal follow-up study

et al. 2022

View full text Add to dashboard Cite

BackgroundBreast cancer patients are at elevated risk of depression during treatment, thus provoking the chance of poor clinical outcomes. This retrospective cohort study aimed to investigate whether integrating Chinese herbal medicines citation(CHM) into conventional cancer therapy could decrease the risk of depression in the long-term breast cancer survivors.MethodsA cohort of patients aged 20–70 years and with newly diagnosed breast cancer during 2000–2008 was identified from a nationwide claims database. In this study, we focused solely on survivors of breast cancer at least1 year after diagnosis. After one-to-one matching for age, sex, and baseline comorbidities, breast cancer patients who received (n = 1,450) and did not receive (n = 1,450) CHM treatment were enrolled. The incidence rate and hazard ratio citation(HR) for depression between the two groups was estimated at the end of 2012. A Cox proportional hazard model was constructed to examine the impact of the CHM use on the risk of depression.ResultsDuring the study period, the incidence rate of depression was significantly lower in the treated cohort than in the untreated cohort [8.57 compared with 11.01 per 1,000 person-years citation(PYs)], and the adjusted HR remained significant at 0.74 (95% CI 0.58–0.94) in a Cox proportional hazards regression model. The corresponding risk further decreasing to 43% among those using CHM for more than 1 year.ConclusionFinding from this investigation indicated that the lower risk of depression observed in breast cancer patients treated with CHM, suggesting that CHM treatment should be considered for disease management toward breast cancer. Yet, the optimal administered dose should be determined in further clinical trials.

show abstract

Section: Discussionmentioning

confidence: 99%

Association of Chinese herbal medicine use with the depression risk among the long-term breast cancer survivors: A longitudinal follow-up study

et al. 2022

View full text Add to dashboard Cite

show abstract

“…The first depression rehabilitation intervention among cancer patients in Palestine, as supported by our literature, is psychological treatment ( 10 , 25 ) supported by Rodin et al ( 35 ), who mentioned that non-pharmacological interventions can include cognitive behavioral therapy, family therapy, palliative care, and is supported by studies carried out in Jordan ( 10 ) and Saudi Arabia ( 48 ). The second intervention is patient and family education ( 53 ), is found in two international studies ( 40 , 45 ).…”

Section: Discussionmentioning

confidence: 69%

“…A study of 125 breast cancer patients treated by radiation therapy at Augusta Victoria Hospital at Jerusalem concluded that depression is a high burden in women with breast cancer having radiotherapy for a long period of treatment. They reported that some interventions are needed to decrease temporary depression, especially in the early stage of radiotherapy treatment, such as psychosocial support services, including screening routinely for psychosocial issues and providing psychological support from social workers and nurses as needed ( 25 ).…”

Section: Resultsmentioning

confidence: 99%

“…Worldwide, pharmacological and many non-pharmacological interventions are combined for depression rehabilitation among cancer patients. Based on our review of five studies from the Gaza Strip and West Bank, depression rehabilitation interventions among cancer patients in Palestine are mostly non-pharmacological interventions used to decrease symptoms of depression, including psychological treatment ( 10 ), psychosocial support services ( 25 ), palliative care, and a holistic approach of care for cancer patients ( 54 ). In addition, the relatives of cancer patients also need to be assessed and managed for symptoms of depression ( 52 ).…”

Section: Discussionmentioning

confidence: 99%

“…Cancer patients have higher levels of depression than non-cancerous patients ( 23 ). Many instruments are used to assess the symptoms of depression in cancer patients, including the Edmonton Symptom Assessment System (ESAS) ( 6 ), the Brief Edinburgh Depression Scale (BEDS) ( 24 ), and the Hospital Anxiety and Depression Scale (HADS) ( 25 ) among others. Integrating early palliative care into the standard oncology care of patients with advanced cancer improves QoL, reduces depression and symptom burden, and leads to survival benefits.…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Rehabilitation interventions for depression symptoms among cancer patients in Palestine: A systematic review

Battat

Marie

2022

Front. Rehabilit. Sci.

View full text Add to dashboard Cite

BackgroundDepression enhances the disease burden in patients with cancer. Psychological interventions and the rehabilitation of depression are required as a part of palliative care for cancer patients to improve their quality of life and mental health.The aim of the study was to review the literature about depression rehabilitation interventions among patients with cancer in Palestine.MethodThe electronic databases used: PubMed, Science Direct, Research Gate, and Google Scholar to search for systematic review articles for the review study.ResultsA total of 23 articles were reviewed, including five from Palestine and five from Arab and Islamic nations. Pharmacological and non-pharmacological interventions used to decrease symptoms of depression and enhance mental health among cancer patients represent the majority of interventions for depression rehabilitation in cancer patients. Interventions for depression rehabilitation among cancer patients in Palestine are only available from the perspective of palliative care, which also involves family education, managing the symptoms of cancer patients, and providing psychological support.ConclusionIn Palestine, non-pharmacological interventions, such as psychological interventions, are the primary options for treating and recovering from symptoms of depression. The management of symptoms in cancer patients also has a favorable impact on mental health and recovery from depression. In Palestine, there is a need for improvement in palliative care, particularly interventions for depressive symptoms. The main reason Palestinian patients with cancer have such limited treatment and recovery options are because of Israeli occupation.

show abstract

Assessment of depression symptoms among cancer patients: a cross-sectional study from a developing country

Battat,

Omair,

WildAli

et al. 2024

Sci Rep

View full text Add to dashboard Cite

Cancer patients experience psychological symptoms such as depression during the cancer treatment period, which increases the burden of symptoms. Depression severity can be assessed using the beck depression inventory (BDI II). The purpose of the study was to use BDI-II scores to measure depression symptoms in cancer patients at a large tertiary hospital in Palestine. A convenience sample of 271 cancer patients was used for a cross-sectional survey. There are descriptions of demographic, clinical, and lifestyle aspects. In addition, the BDI-II is a tool for determining the severity of depression. Two hundred seventy-one patients participated in the survey, for a 95% response rate. Patients ranged in age from 18 to 84 years, with an average age of 47 years. The male-to-female ratio was approximately 1:1, and 59.4% of the patients were outpatients, 153 (56.5%) of whom had hematologic malignancies. Most cancer patients (n = 104, 38.4%) had minimal depression, while 22.5%, 22.1%, and 17.0% had mild, moderate, and severe depression, respectively. Education level, economic status, smoking status, and age were significantly associated with depression. The BDI-II is a useful instrument for monitoring depressive symptoms. The findings support the practice of routinely testing cancer patients for depressive symptoms as part of standard care and referring patients who are at a higher risk of developing psychological morbidity to specialists for treatment as needed.

show abstract

Assessment of Depression and Anxiety in Breast Cancer Patients Undergoing Radiotherapy in Palestine

Cited by 4 publications

References 16 publications

Association of Chinese herbal medicine use with the depression risk among the long-term breast cancer survivors: A longitudinal follow-up study

Association of Chinese herbal medicine use with the depression risk among the long-term breast cancer survivors: A longitudinal follow-up study

Rehabilitation interventions for depression symptoms among cancer patients in Palestine: A systematic review

Assessment of depression symptoms among cancer patients: a cross-sectional study from a developing country

Contact Info

Product

Resources

About